BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7512841)

  • 1. c-kit expression in human megakaryoblastic leukemia cell lines.
    Hu ZB; Ma W; Uphoff CC; Quentmeier H; Drexler HG
    Blood; 1994 Apr; 83(8):2133-44. PubMed ID: 7512841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells.
    Tomeczkowski J; Beilken A; Frick D; Wieland B; König A; Falk MH; Reiter A; Welte K; Sykora KW
    Blood; 1995 Aug; 86(4):1469-80. PubMed ID: 7543307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
    Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
    J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines.
    Hu ZB; Ma W; Uphoff CC; Metge K; Gignac SM; Drexler HG
    Blood; 1993 Sep; 82(5):1599-607. PubMed ID: 8395912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha (TNF alpha) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNF alpha receptors.
    Khoury E; Andre C; Pontvert-Delucq S; Drenou B; Baillou C; Guigon M; Najman A; Lemoine FM
    Blood; 1994 Oct; 84(8):2506-14. PubMed ID: 7522632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
    Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
    Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-kit and kit ligand in human colon carcinoma cells.
    Toyota M; Hinoda Y; Takaoka A; Makiguchi Y; Takahashi T; Itoh F; Imai K; Yachi A
    Tumour Biol; 1993; 14(5):295-302. PubMed ID: 7694350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.
    Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-to-cell interaction of cytokine-dependent myeloblastic line constitutively expressing membrane-bound stem cell factor abrogates cytokine dependency partially through granulocyte-macrophage colony-stimulating factor production.
    Sasaki K; Ikeda K; Ogami K; Takahara J; Irino S
    Blood; 1995 Mar; 85(5):1220-8. PubMed ID: 7532035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the promoter of the proto-oncogene c-kit.
    Chu TY; Besmer P
    Proc Natl Sci Counc Repub China B; 1995 Jan; 19(1):8-18. PubMed ID: 7539532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the c-kit mRNA in human aortic endothelial cells.
    Miyamoto T; Sasaguri Y; Sugama K; Azakami S; Morimatsu M
    Biochem Mol Biol Int; 1994 Oct; 34(3):513-20. PubMed ID: 7530545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and modulation of annexin VIII in human leukemia-lymphoma cell lines.
    Hu ZB; Ma W; Uphoff CC; Drexler HG
    Leuk Res; 1993 Nov; 17(11):949-57. PubMed ID: 8231235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group.
    Cohen PS; Chan JP; Lipkunskaya M; Biedler JL; Seeger RC
    Blood; 1994 Nov; 84(10):3465-72. PubMed ID: 7524740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of c-kit expression in human myeloid cells.
    Brizzi MF; Pavan M; Zini MG; Avanzi GC; Pegoraro L
    Stem Cells; 1993 Jul; 11 Suppl 2():42-8. PubMed ID: 7691327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture.
    Morita S; Tsuchiya S; Fujie H; Itano M; Ohashi Y; Minegishi M; Imaizumi M; Endo M; Takano N; Konno T
    Leukemia; 1996 Jan; 10(1):102-5. PubMed ID: 8558913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.
    Kanakura Y; Furitsu T; Tsujimura T; Butterfield JH; Ashman LK; Ikeda H; Kitayama H; Kanayama Y; Matsuzawa Y; Kitamura Y
    Leukemia; 1994 Apr; 8 Suppl 1():S18-22. PubMed ID: 7512180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines.
    Turner AM; Bennett LG; Lin NL; Wypych J; Bartley TD; Hunt RW; Atkins HL; Langley KE; Parker V; Martin F
    Blood; 1995 Apr; 85(8):2052-8. PubMed ID: 7536489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form.
    Miyazawa K; Williams DA; Gotoh A; Nishimaki J; Broxmeyer HE; Toyama K
    Blood; 1995 Feb; 85(3):641-9. PubMed ID: 7530502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.